Listed

BioCardia, Inc.: Form 10-K for the period ended Dec 31, 2016

Filed with the SEC on Mar 30, 2017 and accepted by EDGAR at Mar 30, 2017, 17:14 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2016-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2016-01-01 to 2016-12-31$576.0kus-gaap:Revenues
Research and development12 months2016-01-01 to 2016-12-31$3.3mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative12 months2016-01-01 to 2016-12-31$4.1mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income12 months2016-01-01 to 2016-12-31−$7.6mus-gaap:OperatingIncomeLoss
Interest expense12 months2016-01-01 to 2016-12-31$1.7mus-gaap:InterestExpense
Income tax12 months2016-01-01 to 2016-12-31$0us-gaap:IncomeTaxExpenseBenefit
Net income12 months2016-01-01 to 2016-12-31−$10.3mus-gaap:NetIncomeLoss
Diluted EPS12 months2016-01-01 to 2016-12-31−$0.10us-gaap:EarningsPerShareBasicAndDiluted
Cash and equivalentsAt period end2016-12-31$21.4mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2016-12-31$21.9mus-gaap:AssetsCurrent
Total assetsAt period end2016-12-31$22.1mus-gaap:Assets
Current liabilitiesAt period end2016-12-31$1.4mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2016-12-31$1.5mus-gaap:Liabilities
Shareholders' equityAt period end2016-12-31$20.6mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001437749-17-005643. Last ingested by Listed: Nov 13, 2026, 15:46 ET. Listed shows no prices and gives no investment advice.